Cuscal (ASX:CCL) has an average rating of buy and mean price target of AU$5.94, according to analysts polled by FactSet.
What else is happening in Research?
Research
Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target
Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target
$NEOV
Research
BofA Securities Upgrades Humana to Buy From Neutral, Raises Price Target to $500 From $410
Humana (HUM) has an average rating of hold and mean price target of $350.54, according to analysts polled by FactSet.Price: $365.15, Change: $-23.56, Percent Change: -6.06%
$HUM
Research
Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target
$QNCX